ÂÜÀòÂÒÂ×

Thoralf Keller is an experienced leader in the biotechnology industry, currently serving as the General Manager (CEO) at Menarini Biotech since September 2017. Prior to this role, Thoralf held key positions at Juno Therapeutics, Inc. as Senior Director of Clinical Manufacturing and Process Development, and at Fresenius Biotech GmbH as Senior Director of Commercial Manufacturing. With a strong background in quality assurance and manufacturing processes gained from roles at Biogen and earlier positions in companies like Trionpharma and Sandoz, Thoralf has developed extensive expertise in biopharmaceutical production. Thoralf Keller holds a Master's degree in Biotechnology from the Technical University of Munich, completed in 1991.